We are researchers at the University of Washington and VA Puget Sound in Seattle. We combine the study of novel blood-based epigenetic biomarkers and established clinical/demographic measures to understand how type 2 diabetes develops. Our goal is to develop new biomarkers to find people at the highest risk of diabetes and its complications (prognostic biomarkers) and people likely to respond to interventions aimed at stopping disease progression (predictive biomarkers).
Contact us at lwander [at] uw [dot] edu.